1.A case of post-malaria neurological syndrome (PMNS) after treatment of falciparum malaria with artesunate and mefloquine
Takashi Odawara ; Takeshi Matsumura ; Takuya Maeda ; Kazushige Washizaki ; Aikichi Iwamoto ; Takeshi Fujii
Tropical Medicine and Health 2009;37(3):125-128
Post-malaria neurological syndrome (PMNS) is a rare complication after the treatment of falciparum malaria. We describe a case of a 56-year-old man who developed ataxia, tremor, and confusion 16 days after a successful treatment of falciparum malaria with artesunate followed by mefloquine. Magnetic resonance imaging of the brain revealed no abnormality, and he recovered spontaneously without any specific treatment including corticosteroids. Inflammatory changes were found in the cerebrospinal fluid, suggesting a localized inflammatory reaction as the cause of the syndrome.
2.HIV-1 tropism.
Aikichi IWAMOTO ; Noriaki HOSOYA ; Ai KAWANA-TACHIKAWA
Protein & Cell 2010;1(6):510-513
Aminoquinolines
;
pharmacology
;
Anti-HIV Agents
;
pharmacology
;
Benzimidazoles
;
pharmacology
;
CCR5 Receptor Antagonists
;
CD4 Antigens
;
metabolism
;
Cyclohexanes
;
pharmacology
;
HIV-1
;
pathogenicity
;
physiology
;
Heterocyclic Compounds
;
pharmacology
;
Heterocyclic Compounds, 1-Ring
;
Humans
;
Maraviroc
;
Piperazines
;
pharmacology
;
Pyrimidines
;
pharmacology
;
Receptors, CCR5
;
metabolism
;
Receptors, CXCR4
;
antagonists & inhibitors
;
metabolism
;
T-Lymphocytes
;
virology
;
Triazoles
;
pharmacology
;
Viral Tropism
3.Conserved arginine residue in the membrane-spanning domain of HIV-1 gp41 is required for efficient membrane fusion.
Yufei LONG ; Fanxia MENG ; Naoyuki KONDO ; Aikichi IWAMOTO ; Zene MATSUDA
Protein & Cell 2011;2(5):369-376
Despite the high mutation rate of HIV-1, the amino acid sequences of the membrane-spanning domain (MSD) of HIV-1 gp41 are well conserved. Arginine residues are rarely found in single membrane-spanning domains, yet an arginine residue, R(696) (the numbering is based on that of HXB2), is highly conserved in HIV-1 gp41. To examine the role of R(696), it was mutated to K, A, I, L, D, E, N, and Q. Most of these substitutions did not affect the expression, processing or surface distribution of the envelope protein (Env). However, a syncytia formation assay showed that the substitution of R(696) with amino acid residues other than K, a naturally observed mutation in the gp41 MSD, decreased fusion activity. Substitution with hydrophobic amino acid residues (A, I, and L) resulted in a modest decrease, while substitution with D or E, potentially negatively-charged residues, almost abolished the syncytia formation. All the fusion-defective mutants showed slower kinetics with the cell-based dual split protein (DSP) assay that scores the degree of membrane fusion based on pore formation between fusing cells. Interestingly, the D and E substitutions did show some fusion activity in the DSP assays, suggesting that proteins containing D or E substitutions retained some fusion pore-forming capability. However, nascent pores failed to develop, due probably to impaired activity in the pore enlargement process. Our data show the importance of this conserved arginine residue for efficient membrane fusion.
Amino Acid Substitution
;
Animals
;
Arginine
;
chemistry
;
metabolism
;
Cell Line
;
Cercopithecus aethiops
;
HIV Envelope Protein gp41
;
chemistry
;
metabolism
;
HIV-1
;
metabolism
;
Humans
;
Kinetics
;
Membrane Fusion
;
physiology
;
Mutation
;
Protein Structure, Tertiary